The end of the BREXIT transition period has no effect on European patents or patent applications. The European Patent Office (EPO) is European in name […]
The Leahy-Smith America Invents Act (“AIA”) created three new procedures to be presided over by the newly created Patent Trial and Appeal Board (“PTAB”). Two […]
While the early hypothesis that chimeric antigen receptors (CARs) could be expressed in T-cells (CAR T-cells) for use as therapeutic agents was more than three […]
With the passage of the America Invents Act (AIA), the U.S. moved from a First-To-Invent system to a First-Inventor-To-File system in order to harmonize the […]